Published in JAMA on July 25, 1980
Postmenopausal osteoporosis. Br Med J (Clin Res Ed) (1983) 1.77
Postmenopausal oestrogen treatment and stroke: a prospective study. BMJ (1988) 1.37
Cardiovascular disease and hormone replacement treatment: a pilot case-control study. Br Med J (Clin Res Ed) (1981) 1.15
Smoking prevalence and associated risk factors in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 0.90
Relation between cigarette smoking and use of hormonal replacement therapy for menopausal symptoms. J Epidemiol Community Health (1987) 0.88
The risks and benefits of long-term estrogen replacement therapy. Public Health Rep (1990) 0.78
Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits. Br J Gen Pract (1992) 0.75
Estrogen replacement therapy (ERT) in high-risk cancer patients. Yale J Biol Med (1992) 0.75
Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet (1999) 13.67
Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst (1982) 13.25
Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA (2001) 11.31
Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol (1974) 9.27
Evidence on screening for breast cancer from a randomized trial. Cancer (1977) 7.91
Estimation of relative risk from individually matched series. Biometrics (1970) 6.47
Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst (1993) 6.02
Periodic breast cancer screening in reducing mortality from breast cancer. JAMA (1971) 5.91
Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes (1965) 5.42
Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Ann Intern Med (1998) 4.81
Stratification by a multivariate confounder score. Am J Epidemiol (1976) 4.58
Confounding: essence and detection. Am J Epidemiol (1981) 4.47
Standardization of risk ratios. Am J Epidemiol (1972) 4.32
Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol (1996) 4.25
Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet (1996) 4.21
CHANGES IN THE ELECTROPHORETIC PATTERN IN LYMPH AND SERUM IN EXPERIMENTAL BURNS. J Clin Invest (1943) 4.20
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med (2000) 4.07
Asthma mortality. Why the United States was spared an epidemic of deaths due to asthma. Am Rev Respir Dis (1972) 3.77
Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA (1993) 3.71
The reluctant participant in a breast cancer screening program. Public Health Rep (1968) 3.60
Utilization of health and mental health services. Three Epidemiologic Catchment Area sites. Arch Gen Psychiatry (1984) 3.55
Drug prescribing and use in an American community. Ann Intern Med (1972) 3.55
A comparison of the requirements for primary care physicians in HMOs with projections made by the GMENAC. N Engl J Med (1986) 3.54
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet (1997) 3.40
Chemical basis for the histological use of safranin O in the study of articular cartilage. J Bone Joint Surg Am (1971) 3.37
Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol (1986) 3.34
Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health (1983) 3.33
Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore. Arch Gen Psychiatry (1985) 3.18
Oral-contraceptive use in relation to myocardial infarction. Lancet (1979) 3.04
An alternative to the proportionate mortality ratio. Am J Epidemiol (1981) 3.03
The need for randomization in the study of intended effects. Stat Med (1984) 3.01
Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med (1968) 2.99
Concern Early lung cancer action project: initial findings on repeat screenings. Cancer (2001) 2.99
A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst (1991) 2.96
Comprehensive drug surveillance. JAMA (1970) 2.92
Smell identification ability: changes with age. Science (1984) 2.87
Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med (1996) 2.83
Mammography and clinical examination in mass screening for cancer of the breast. Cancer (1967) 2.80
Measuring postoperative complications in general surgery patients using an outcomes-based strategy: comparison with complications presented at morbidity and mortality rounds. Surgery (1997) 2.76
Functional recovery and medical costs of trauma: an analysis by type and severity of injury. J Trauma (1988) 2.74
The history of malariotherapy for neurosyphilis. Modern parallels. JAMA (1992) 2.73
Macromolecular models of proteinpolysaccharides from bovine nasal cartilage based on electron microscopic studies. J Biol Chem (1970) 2.70
Drug surveillance utilizing nurse monitors. An epidemiological approach. Lancet (1966) 2.69
Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr (1983) 2.65
Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol (1977) 2.65
The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med (1985) 2.64
Individual matching with multiple controls in the case of all-or-none responses. Biometrics (1969) 2.58
Induction of an active transport system for glucose 6-phosphate in Escherichia coli. Arch Biochem Biophys (1966) 2.53
Why does family homelessness occur? A case-control study. Am J Public Health (1988) 2.52
Mental health and social characteristics of the homeless: a survey of mission users. Am J Public Health (1986) 2.50
Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.49
A case-control study of baldness in relation to myocardial infarction in men. JAMA (1993) 2.49
The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med (1998) 2.46
The estimation of oxygen consumption. Cardiovasc Res (1970) 2.40
Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol (1979) 2.40
Noninvasive tests in the initial evaluation of heart murmurs in children. N Engl J Med (1983) 2.39
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
Impact of efforts to increase participation in repetitive screenings for early breast cancer detection. Am J Public Health (1972) 2.35
Breast cancer and cigarette smoking: a hypothesis. Am J Epidemiol (1991) 2.35
Proteoglycans from bovine nasal cartilage. Properties of a soluble form of link protein. J Biol Chem (1979) 2.32
Race, family income, and low birth weight. Am J Epidemiol (1991) 2.30
Components of the crude risk ratio. Am J Epidemiol (1972) 2.25
Current practice of artificial insemination by donor in the United States. N Engl J Med (1979) 2.24
Severe hyperphosphatemia and hypocalcemia caused by bowel preparation for colonoscopy using oral sodium phosphate in end-stage renal disease. Endoscopy (2005) 2.23
Medical economics survey-methods study: cost-effectiveness of alternative survey strategies. Med Care (1978) 2.22
Sample size calculations for clinical pharmacology studies. Clin Pharmacol Ther (1986) 2.21
Dexamethasone and dexamethasone-aspirin in the treatment of chronic rheumatoid arthritis. A controlled trial. Lancet (1965) 2.18
Limited Pap screening associated with reduced risk of cervical cancer in South Africa. Int J Epidemiol (2003) 2.17
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology (1999) 2.16
The search for risk factors in breast cancer. Am J Public Health Nations Health (1968) 2.16
The economic impact of traumatic injuries. One-year treatment-related expenditures. JAMA (1988) 2.15
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A (1980) 2.13
The Abbreviated Injury Scale and Injury Severity Score. Levels of inter- and intrarater reliability. Med Care (1985) 2.11
Methyl-coenzyme M, an intermediate in methanogenic dissimilation of C1 compounds by Methanosarcina barkeri. J Bacteriol (1980) 2.11
Evidence in medicine: invited commentary. CMAJ (1998) 2.11
Occupational mortality studies. Principles of validity. Scand J Work Environ Health (1982) 2.10
Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh (1975) 2.10
An ultrastructural study of normal young adult human articular cartilage. J Bone Joint Surg Am (1968) 2.07
Follow-up of a large cohort of Black women. Am J Epidemiol (2001) 2.05
A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol (1999) 2.04
Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion. Arch Gen Psychiatry (1999) 2.03
Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial. Thromb Haemost (2014) 2.02
Prepregnant weight in relation to risk of neural tube defects. JAMA (1996) 2.02